Scientists from the Miller School of Medicine at the University of Miami have reported their recent work to develop small-molecule inhibitors of the CD40-CD40L (CD154) costimulatory protein-protein ...

Novel immunoproteasome inhibitors (IPIs) have higher specificity for immune cells and have not been investigated for AMR in cardiac transplant patients. We sought to evaluate IPI effect on AMR in a ...

Intra-aortic balloon pump treatment has the potential to stabilize deteriorating heart failure patients, and reverse kidney and liver failure, thus enabling HTx to be performed in haemodynamically ...

College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea College of Pharmacy, Natural Products Research Institute, Seoul ...

and one aortoaortic bypass owing to aortic aneurysm. Two patients had received a previous kidney transplant, but it had failed. The underlying diseases were diabetes mellitus (12%), hypertension ...

Opens in a new tab or window Undersized donor hearts were indeed associated with more post-transplantation mortality ... who invented the intra-aortic balloon pump (IABP), died at age 98.

Impact and progress Frontiers' impact Progress Report 2022 All progress reports ...

Our laboratory is also an integral component of the Broccoli Center for Aortic Diseases, further enhancing our research capabilities and clinical impact. The Clinical and Translational Research ...

Currently, he is on life support, waiting to reach a level of health that will allow him to be placed on the heart transplant list ... with Interrupted Aortic Arch (IAA) type B, a heart ...